Impact Biomedical Inc. 8-K Filing
Ticker: IBO · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Impact Biomedical Inc. (ticker: IBO) to the SEC on Jan 29, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (nge on which registered Common Stock, $0.001 par value per share N/A N/A Indic).
How long is this filing?
Impact Biomedical Inc.'s 8-K filing is 2 pages with approximately 501 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-29 16:43:17
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share N/A N/A Indic
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 28KB
- ex99-1_001.jpg (GRAPHIC) — 250KB
- ex99-1_002.jpg (GRAPHIC) — 568KB
- ex99-1_003.jpg (GRAPHIC) — 382KB
- ex99-1_004.jpg (GRAPHIC) — 284KB
- ex99-1_005.jpg (GRAPHIC) — 322KB
- ex99-1_006.jpg (GRAPHIC) — 249KB
- ex99-1_007.jpg (GRAPHIC) — 248KB
- ex99-1_008.jpg (GRAPHIC) — 374KB
- ex99-1_009.jpg (GRAPHIC) — 314KB
- ex99-1_010.jpg (GRAPHIC) — 385KB
- ex99-1_011.jpg (GRAPHIC) — 356KB
- ex99-1_012.jpg (GRAPHIC) — 313KB
- ex99-1_013.jpg (GRAPHIC) — 195KB
- ex99-1_014.jpg (GRAPHIC) — 214KB
- ex99-1_015.jpg (GRAPHIC) — 160KB
- ex99-1_016.jpg (GRAPHIC) — 350KB
- ex99-1_017.jpg (GRAPHIC) — 509KB
- ex99-1_018.jpg (GRAPHIC) — 291KB
- ex99-1_019.jpg (GRAPHIC) — 315KB
- 0001493152-25-004161.txt ( ) — 8608KB
- ibo-20250129.xsd (EX-101.SCH) — 3KB
- ibo-20250129_lab.xml (EX-101.LAB) — 33KB
- ibo-20250129_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Company Investor Presentation dated, as of January 2025 104 Cover page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. IMPACT BIOMEDICAL INC. Date: January 29, 2025 By: /s/ Frank D. Heuszel Name: Frank D. Heuszel Title: Chief Executive Officer